Published: 25 May 2021
Author(s): Jose F. Varona, Rodrigo Madurga, Francisco Peñalver, Elena Abarca, Cristina Almirall, Marta Cruz, Enrique Ramos, Jose María Castellano-Vazquez
Issue: July 2021
Section: Original article

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to an unprecedented health emergency, causing over 125 million confirmed cases and over 2.5 million deaths worldwide as of March 2021 [1]. Understanding the long-term immunological response in infected individuals will be central in defeating the COVID-19 pandemic, and understanding humoral kinetics, timing, and persistence of SARS-CoV-2 antibodies after natural infection, will be essential to ensure an appropriate vaccination strategy.

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness